title: Nocturia: morbidity and management in adults.
abstract: Nocturia is an increasingly prevalent and bothersome urinary symptom associated with considerable impact and morbidity in later life. Nocturnal frequency is associated with a number of underlying pathologies, both related and unrelated to the lower urinary tract. Following careful assessment, diagnosis and management, the condition is amenable to amelioration, if not complete cure in the majority of cases. This paper outlines the epidemiology, underlying pathophysiology and diseases associated with nocturia and reviews current treatment strategies.
authors: Department of Geriatric Medicine, University College Hospital, 25 Grafton Way, London WC1E 6AU, UK. a.wagg@ucl.ac.uk
authors: A
authors: A
authors: Wagg
authors: K-E
authors: KE
authors: Andersson
authors: L
authors: L
authors: Cardozo
authors: C
authors: C
authors: Chapple
authors: M
authors: M
authors: Kirby
authors: C
authors: C
authors: Kelleher
authors: G
authors: G
authors: Lose
authors: I
authors: I
authors: Milsom
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D001748:Urinary Bladder Neck Obstruction / Q000188:drug therapy; D014555:Urination Disorders / Q000209:etiology* / Q000503:physiopathology
chemical_list: D000317:Adrenergic alpha-Antagonists; D004232:Diuretics; D003894:Deamino Arginine Vasopressin